JPRN-UMIN000030234已完成未知
Clinical usefulness of serum Mac-2 binding protein glycosylation isomer in decompensated cirrhosis - Serum M2BPGi in decompensated cirrhosis
Kitasato University School of Medicine0 个研究点目标入组 500 人开始时间: 2017年12月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cases regarded by doctors as inappropriate for the enrollment for some reasons
研究者
相似试验
已完成
不适用
Clinical usefulness of serum Mac-2 binding protein glycosylation isomer (M2BPGi) as a novel biomarker in respiratory diseasesRespiratory diseasesJPRN-UMIN000022606Hamamatsu University School of Medicine200
已完成
不适用
sefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomyThe patients with liver diseases who were undergoing hepatic resectionsJPRN-UMIN000036699niversity of Miyazaki, Faculty of Medicine115
已完成
不适用
The usefulness of serum APM2 as a predictable marker for the response to platinum based antineoplastic drugs.Hepatocellular carcinoma, Gastric cancer, Esophageal cancerJPRN-UMIN000028487Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University100
已完成
2 期
Phase IIb study on the safety and efficacy of BM32, a recombinant hypoallergenic vaccine for immunotherapy of grass pollen allergygrass pollen allergy10001708NL-OMON39223Biomay AG20
招募中
不适用
The use of novel protein biomarkers in predicting clinical outcomes in patients with localised and metastatic colorectal cancerColorectal cancerACTRN12610000776000Cancer Institute NSW200